F
Farrokh Saidi
Researcher at Tehran University of Medical Sciences
Publications - 4
Citations - 416
Farrokh Saidi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Cancer & Cohort study. The author has an hindex of 3, co-authored 4 publications receiving 386 citations.
Papers
More filters
Journal ArticleDOI
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study
Farhad Islami,Akram Pourshams,Dariush Nasrollahzadeh,Dariush Nasrollahzadeh,Farin Kamangar,Saman Fahimi,Saman Fahimi,Ramin Shakeri,Behnoush Abedi-Ardekani,Shahin Merat,Homayoon Vahedi,Shahryar Semnani,Christian C. Abnet,Paul Brennan,Henrik Møller,Farrokh Saidi,Sanford M Dawsey,Reza Malekzadeh,Paolo Boffetta +18 more
TL;DR: Drinking hot tea, a habit common in Golestan province, was strongly associated with a higher risk of oesophageal cancer, and a strong agreement was found between responses to the questions on temperature at which tea was drunk and interval from tea being poured to being drunk.
Journal ArticleDOI
Golestan cohort study of oesophageal cancer: feasibility and first results
Akram Pourshams,Mitra Saadatian-Elahi,Mehdi Nouraie,Akbar Fazeltabar Malekshah,Nasser Rakhshani,R Salahi,Ali Yoonessi,Shahryar Semnani,Farhad Islami,M Sotoudeh,Saman Fahimi,Saman Fahimi,Alireza Sadjadi,Dariush Nasrollahzadeh,Karim Aghcheli,Farin Kamangar,Christian C. Abnet,Farrokh Saidi,Vikash Sewram,Paul T. Strickland,Sanford M. Dawsey,Paul Brennan,Paolo Boffetta,Reza Malekzadeh +23 more
TL;DR: In this paper, the authors investigated the incidence of oesophageal cancer (EC) in the Golestan province of North-East Iran, where they invited 1349 rural and urban inhabitants of the province aged 35-80 to undergo extensive lifestyle interviews and to provide biological samples.
Journal ArticleDOI
Epidermal growth factor receptor ( EGFR ) mutations and expression in squamous cell carcinoma of the esophagus in central Asia
Behnoush Abedi-Ardekani,Nazir Ahmad Dar,Nazir Ahmad Dar,Mohammad Muzaffar Mir,Showkat Ahmad Zargar,M Muqbool Lone,Ghyslaine Martel-Planche,Stephanie Villar,M. Mounawar,Farrokh Saidi,Reza Malekzadeh,Pierre Hainaut +11 more
TL;DR: Overall, EGFR mutations appear to be a rare event in ESCC in high incidence areas of central Asia, although a very small proportion of cases may harbor mutations predicting sensitivity to anti-Egfr drugs.
Journal ArticleDOI
TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.
Dariush Nasrollahzadeh,Gholamreza Roshandel,Tiffany M. Delhomme,Patrice H. Avogbe,Matthieu Foll,Farrokh Saidi,Hossein Poustchi,Masoud Sotoudeh,Reza Malekzadeh,Paul Brennan,James McKay,Pierre Hainaut,Behnoush Abedi-Ardekani +12 more
TL;DR: In this article, the concordance of TP53 mutations in tumor tissue and cfDNA extracted from archival serum leftover from 42 cases and 39 matched controls in a high-risk area of Northern Iran (Golestan).